3-fluoro-4'-(2-(1-(2-(3-hydroxyphenoxy)ethyl)-5-neopentyl-1H-imidazol-2-yl)ethyl)biphenyl-2-carboxylic acid

ID: ALA4435571

Chembl Id: CHEMBL4435571

PubChem CID: 155511392

Max Phase: Preclinical

Molecular Formula: C31H33FN2O4

Molecular Weight: 516.61

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C)Cc1cnc(CCc2ccc(-c3cccc(F)c3C(=O)O)cc2)n1CCOc1cccc(O)c1

Standard InChI:  InChI=1S/C31H33FN2O4/c1-31(2,3)19-23-20-33-28(34(23)16-17-38-25-7-4-6-24(35)18-25)15-12-21-10-13-22(14-11-21)26-8-5-9-27(32)29(26)30(36)37/h4-11,13-14,18,20,35H,12,15-17,19H2,1-3H3,(H,36,37)

Standard InChI Key:  KDSHVIVQYIAHFB-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4435571

    ---

Associated Targets(Human)

BRS3 Tchem Bombesin receptor subtype-3 (700 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Brs3 Bombesin receptor subtype-3 (412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 516.61Molecular Weight (Monoisotopic): 516.2424AlogP: 6.55#Rotatable Bonds: 10
Polar Surface Area: 84.58Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 2.93CX Basic pKa: 7.25CX LogP: 5.72CX LogD: 5.34
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.25Np Likeness Score: -0.73

References

1. Kiyotsuka Y, Shimada K, Kobayashi S, Suzuki M, Akiu M, Asano M, Sogawa Y, Hara T, Konishi M, Abe-Ohya R, Izumi M, Nagai Y, Yoshida K, Abe Y, Takamori H, Takahashi H..  (2016)  Synthesis and biological evaluation of novel imidazol-1-ylacetic acid derivatives as non-brain penetrant bombesin receptor subtype-3 (BRS-3) agonists.,  26  (17): [PMID:27491709] [10.1016/j.bmcl.2016.07.056]

Source